Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Medline Inc. (NASDAQ: MDLN) Faces Possible Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Tickers MDLN
Exposures Product Safety
News headline image
Medline Inc. (NASDAQ: MDLN) Faces Possible Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Via TheNewswire.com
Tickers MDLN
Exposures Product Safety
News headline image
Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness ↗
Via Benzinga
Tickers LLY
Exposures Product Safety
Currently Approved Drug Could Boost Immunotherapy Against Liver Cancer
Via Investor Brand Network
Tickers BMWYY CLDI
Exposures Product Safety
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT
Exposures Intellectual Property Product Safety
NetworkNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances SPC-15 Intranasal PTSD Program With Device Robustness Study
Via Investor Brand Network
Tickers SILO
Exposures Product Safety
News headline image
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
Via FinancialNewsMedia
Tickers CMPS DFTX GHRS HELP JNJ
Exposures Product Safety
News headline image
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device
Via Newsfile
Tickers COCH
Exposures Product Safety
News headline image
OS Therapies Provides U.S. Regulatory Update
Via Newsfile
Tickers ARM OSTX
Exposures Product Safety
News headline image
United States Biosimilar Market Size Projected to Reach USD 33.2 Billion by 2034, Growing at a CAGR of 17.60% ↗
Via Talk Markets
Topics Intellectual Property
Exposures Intellectual Property Product Safety
News headline image
Joint Statement on Warning to Pharmacists About Diverted HIV Medicines Being Sold on Online Pharmacy-to-Pharmacy Platforms
Via 24-7 Press Release
Topics Economy Fraud
Tickers META
Exposures Legal Product Safety Supply Chain
News headline image
Infectious Disease Diagnostics Market: Size, Trends, and Growth Dynamics ↗
Via Talk Markets
Exposures Product Safety
News headline image
Zoetis Inc. (ZTS) Investors: July 27, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Fraud Lawsuit
Tickers ZTS
Exposures Financial Legal Product Safety
News headline image
Zoetis Inc. (ZTS) Investors: July 27, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers ZTS
Exposures Financial Legal Product Safety
News headline image
Artivion Seeks To Tap $150 Million US Market Opportunity With FDA Approval ↗
Via Benzinga
Exposures Product Safety
News headline image
AbbVie Extends Reach Across Dermatology Markets With Dual Regulatory Wins ↗
Via Benzinga
Exposures Product Safety
News headline image
FDA Approval Positions United Therapeutics To Broaden Access To Donor Lungs ↗
Via Benzinga
Exposures Product Safety
News headline image
AI-Powered Neuropsychiatry, FDA Regulatory Momentum, Commercial Ketamine Launch Position NRx Pharmaceuticals for Potential Breakout Growth in 2026
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
Growing Scientific Evidence Links E-Cigarette Chemicals to Heart Health Risks
Via NewMediaWire
Exposures Product Safety
News headline image
Kaplan Fox Reminds Investors of Medline Inc. (NASDAQ: MDLN) to an Investigation of Possible Securities Law Violations
Via TheNewswire.com
Tickers MDLN
Exposures Product Safety
News headline image
Kaplan Fox Reminds Investors of Medline Inc. (NASDAQ: MDLN) to an Investigation of Possible Securities Law Violations
Via NewMediaWire
Tickers MDLN
Exposures Product Safety
News headline image
Larimar Stock Slides 15% Despite FDA Backing Rolling Submission For Rare Disease Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
FDA Manufacturing Issues Delay Lantheus' Tumor Imaging Kit ↗
Via Benzinga
Exposures Product Safety
NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Enrolls First Patient in Phase 2 Depression Trial
Via Investor Brand Network
Tickers TNXP
Exposures COVID-19 Product Safety
News headline image
Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease ↗
Via Benzinga
Exposures Product Safety
News headline image
First Patients Treated via FDA-Cleared Transcranial Magnetic Stimulation, Plus FDA Grant on D-Cycloserine-Based Drug for Depression: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Topics Government
Tickers NRXP
Exposures Political Product Safety
News headline image
Glass Storage Jars Airtight lid, Food-Grade & Customizable for Wholesale
Via AB Newswire
Exposures Product Safety
News headline image
Choosing Safe GLP-1 Weight Loss Telehealth Providers: RN Guide Released
Via Press Release Distribution Service
Exposures Product Safety
News headline image
The Economic Boom of Private Label Oral Care: Why Brands Are Outsourcing Manufacturing in 2026
Via GlobePRwire
Topics Economy Supply Chain
Exposures Product Safety Supply Chain
News headline image
What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline ↗
Via The Motley Fool
Topics Regulatory Compliance
Tickers SVRA
Exposures Legal Product Safety Regulatory
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.